HALVING OF MORTALITY OF SEVERE MELIOIDOSIS BY CEFTAZIDIME
- 1 September 1989
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 334 (8665), 697-701
- https://doi.org/10.1016/s0140-6736(89)90768-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.Journal of Clinical Pathology, 1989
- Melioidosis: A Major Cause of Community-Acquired Septicemia in Northeastern ThailandThe Journal of Infectious Diseases, 1989
- In vitro activities of the newer beta-lactam and quinolone antimicrobial agents against Pseudomonas pseudomalleiAntimicrobial Agents and Chemotherapy, 1988
- ANTIBIOTIC RESISTANCE IN PSEUDOMONAS PSEUDOMALLEIThe Lancet, 1988
- Renal Failure in MelioidosisNephron, 1987
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- APACHE IICritical Care Medicine, 1985
- CeftazidimeDrugs, 1985
- An improved screening technique for isolation of pseudomonas pseudomallei from clinical specimensPathology, 1979
- Pseudomonas pseudomallei: Susceptibility to Chemotherapeutic AgentsThe Journal of Infectious Diseases, 1970